SeaSpine Gains FDA Clearance for Amended Indication for NanoMetalene Surface Technology
SeaSpine is permitted to describe the surface technology as offering a "microscopic roughened surface with nano-scale features” and amends indications across 12 implant systems. Dec 15, 2020